BASF beefs up ibuprofen API capacity with projects in U.S. and Europe
admin 28th June 2017 Uncategorised 0Ibuprofen is one of the products that BASF held onto when it sold off the rest of its API business several years ago. The German company now intends to expand capacity for the ingredient significantly.
More: BASF beefs up ibuprofen API capacity with projects in U.S. and Europe
Source: fierce